Five-year overview
DKK million |
|
2021 |
|
2022 |
|
2023 |
|
2024 |
|
2025 |
|
Change |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial performance |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Net sales |
|
140,800 |
|
176,954 |
|
232,261 |
|
290,403 |
|
309,064 |
|
6.4% |
|||||||||||||
Sales growth as reported |
|
10.9% |
|
25.7% |
|
31.3% |
|
25.0% |
|
6.4% |
|
|
|||||||||||||
Sales growth in constant exchange rates1 |
|
13.8% |
|
16.4% |
|
35.6% |
|
25.7% |
|
10.3% |
|
|
|||||||||||||
Operating profit |
|
58,644 |
|
74,809 |
|
102,574 |
|
128,339 |
|
127,658 |
|
(0.5%) |
|||||||||||||
Operating profit growth as reported |
|
8.3% |
|
27.6% |
|
37.1% |
|
25.1% |
|
(0.5%) |
|
|
|||||||||||||
Operating profit growth in constant exchange rates1 |
|
12.7% |
|
14.6% |
|
43.7% |
|
26.2% |
|
6.0% |
|
|
|||||||||||||
Depreciation, amortisation and impairment losses |
|
6,025 |
|
7,362 |
|
9,413 |
|
19,107 |
|
21,982 |
|
15.0% |
|||||||||||||
EBITDA1, 2 |
|
64,669 |
|
82,171 |
|
111,987 |
|
147,446 |
|
149,640 |
|
1.5% |
|||||||||||||
EBITDA growth as reported1, 2 |
|
8.0% |
|
27.1% |
|
36.3% |
|
31.7% |
|
1.5% |
|
|
|||||||||||||
EBITDA growth in constant exchange rates1, 2 |
|
12.0% |
|
14.9% |
|
42.4% |
|
32.7% |
|
7.3% |
|
|
|||||||||||||
Net financials |
|
436 |
|
(5,747) |
|
2,100 |
|
(1,148) |
|
2,882 |
|
|
|||||||||||||
Profit before income taxes |
|
59,080 |
|
69,062 |
|
104,674 |
|
127,191 |
|
130,540 |
|
2.6% |
|||||||||||||
Effective tax rate3 |
|
19.2% |
|
19.6% |
|
20.1% |
|
20.6% |
|
21.5% |
|
|
|||||||||||||
Net profit |
|
47,757 |
|
55,525 |
|
83,683 |
|
100,988 |
|
102,434 |
|
1.4% |
|||||||||||||
Adjusted net profit1 |
|
49,146 |
|
57,370 |
|
86,229 |
|
110,557 |
|
116,407 |
|
|
|||||||||||||
Purchase of property, plant and equipment |
|
6,335 |
|
12,146 |
|
25,806 |
|
47,164 |
|
60,140 |
|
28% |
|||||||||||||
Purchase of intangible assets |
|
1,050 |
|
2,607 |
|
13,090 |
|
4,145 |
|
29,973 |
|
623% |
|||||||||||||
Cash used for acquisition of businesses |
|
18,283 |
|
7,075 |
|
— |
|
82,163 |
|
— |
|
|
|||||||||||||
Free cash flow1 |
|
29,319 |
|
57,362 |
|
68,326 |
|
(14,707) |
|
28,295 |
|
|
|||||||||||||
Total assets |
|
194,508 |
|
241,257 |
|
314,486 |
|
465,630 |
|
542,902 |
|
17% |
|||||||||||||
Net debt1 |
|
(5,031) |
|
2,319 |
|
8,950 |
|
(69,713) |
|
(95,424) |
|
37% |
|||||||||||||
Equity |
|
70,746 |
|
83,486 |
|
106,561 |
|
143,486 |
|
194,047 |
|
35% |
|||||||||||||
Financial ratios |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Gross margin3 |
|
83.2% |
|
83.9% |
|
84.6% |
|
84.7% |
|
81.0% |
|
|
|||||||||||||
Sales and distribution costs in percentage of sales |
|
26.3% |
|
26.1% |
|
24.4% |
|
21.4% |
|
20.8% |
|
|
|||||||||||||
Research and development costs in percentage of sales |
|
12.6% |
|
13.6% |
|
14.0% |
|
16.6% |
|
16.8% |
|
|
|||||||||||||
Cash to earnings1 |
|
61.4% |
|
103.3% |
|
81.6% |
|
(14.6%) |
|
27.6% |
|
|
|||||||||||||
Operating margin3 |
|
41.7% |
|
42.3% |
|
44.2% |
|
44.2% |
|
41.3% |
|
|
|||||||||||||
Net profit margin3 |
|
33.9% |
|
31.4% |
|
36.0% |
|
34.8% |
|
33.1% |
|
|
|||||||||||||
Return on invested capital1 |
|
69.0% |
|
73.6% |
|
88.5% |
|
63.9% |
|
39.3% |
|
|
|||||||||||||
Share performance and capital allocation |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Basic earnings per share/ |
|
10.40 |
|
12.26 |
|
18.67 |
|
22.67 |
|
23.06 |
|
1.7% |
|||||||||||||
Diluted earnings per share/ |
|
10.37 |
|
12.22 |
|
18.62 |
|
22.63 |
|
23.03 |
|
1.8% |
|||||||||||||
Adjusted diluted earnings per share/ |
|
10.67 |
|
12.62 |
|
19.18 |
|
24.77 |
|
26.17 |
|
5.7% |
|||||||||||||
Total number of shares (million), end of year |
|
4,620 |
|
4,560 |
|
4,510 |
|
4,465 |
|
4,465 |
|
0.0% |
|||||||||||||
Dividend per share in DKK4 |
|
5.20 |
|
6.20 |
|
9.40 |
|
11.40 |
|
11.70 |
|
2.6% |
|||||||||||||
Total dividend (DKK million)4 |
|
23,711 |
|
27,950 |
|
41,987 |
|
50,683 |
|
51,975 |
|
2.5% |
|||||||||||||
Dividend payout ratio3 |
|
49.6% |
|
50.3% |
|
50.2% |
|
50.2% |
|
50.7% |
|
|
|||||||||||||
Share repurchases (DKK million) |
|
19,447 |
|
24,086 |
|
29,924 |
|
20,181 |
|
1,388 |
|
(93%) |
|||||||||||||
Closing share price (DKK) |
|
368 |
|
469 |
|
698 |
|
624 |
|
325 |
|
(48%) |
|||||||||||||
Sustainability performance |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total number of patients reached |
|
34.9 |
|
36.9 |
|
41.6 |
|
45.2 |
|
45.6 |
|
1% |
|||||||||||||
Total number of employees (headcount) |
|
48,478 |
|
55,185 |
|
64,319 |
|
77,349 |
|
69,505 |
|
(10%) |
|||||||||||||
Total GHG6 emissions – market-based (1,000 tonnes CO2e) |
|
— |
|
— |
|
1,836 |
|
2,261 |
|
2,690 |
|
19% |
|||||||||||||
Plastic footprint per patient (kg/patient) |
|
— |
|
— |
|
— |
|
0.38 |
|
0.36 |
|
(5%) |
|||||||||||||
|
|||||||||||||||||||||||||